


































Prohibitins are ubiquitous, evolutionarily strongly 
conserved proteins that localize to mitochondria. The 
eukaryotic mitochondrial prohibitin (PHB) complex 
comprises two highly homologous subunits, PHB-1 
and PHB-2 (around 50% amino acid sequence identity 
and 60% similarity). PHB-1 and PHB-2, with 
molecular weights of 32 and 34 kDa respectively, 
associate to form a ring-like macromolecular structure 
of approximately 1 MD [1] with a diameter of 20-25 
nm [2]. This high molecular weight complex has been 
identified in yeast, Caenorhabditis elegans and 
mammals [3-5]. PHB-1 and PHB-2 are interdependent 
for protein complex formation, and elimination of 
either PHB-1 or PHB-2 results in the absence of the 
whole PHB complex [3,6-8]. The PHB complex sits at 
the mitochondrial inner membrane facing the inter 
membrane space. However, detailed structural data 
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Several roles have been proposed for mitochondrial 
prohibitins. First, the PHB complex was suggested to 
regulate membrane protein degradation by the 
mitochondrial m-AAA protease [5]. Later, a function as 
a membrane-bound chaperone, which holds and 
stabilizes newly synthesized mitochondrial-encoded 
proteins was proposed [4, 9]. PHB proteins might also 
play a role in stabilizing the mitochondrial genome [10-
12]. In addition, the PHB complex has been implicated 
in mitochondrial morphogenesis by stabilizing OPA-1 
[8], and by functioning as scaffold proteins that recruit 
membrane proteins to a specific lipid environment [13]. 
However, the true biochemical function of the 
mitochondrial prohibitin complex remains unknown. 
Accumulating evidence suggests that prohibitins func-
tion together within mitochondria [8,14-17] (reviewed 
in [9,18,19]), however, a number of diverse cellular 
functions have also been attributed to both PHB1 and 
PHB2 in other cellular compartments. These include a 




















Abstract: While specific signalling cascades  involved  in aging, such as  the  insulin/IGF‐1 pathway, are well‐described,  the
actual metabolic changes they elicit to prolong  lifespan remain obscure. Nevertheless, the tuning of cellular metabolism
towards  maximal  survival  is  the  molecular  basis  of  longevity.  The  eukaryotic  mitochondrial  prohibitin  complex  is  a
macromolecular structure at the inner mitochondrial membrane, implicated in several important cellular processes such as
mitochondrial biogenesis and  function, molecular  signalling,  replicative  senescence, and  cell death. Recent  studies  in C.
elegans have revealed that prohibitin differentially influences aging by moderating fat metabolism and energy production,
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and cell surface signaling (reviewed in [20-22]). 
 
The high degree of evolutionary conservation of the 
PHB proteins (66/83% identity/similarity between 
human and C. elegans, and 53/79% identity/similarity 
between C. elegans and  Saccharomyces cerevisiae) 
suggests an essential cellular function. Although 
disruption of the PHB complex in S. cerevisiae does not 
result in any observable growth phenotype under 
laboratory conditions [6,23], in C. elegans and in mice, 
prohibitins are required for embryonic development 
[3,7,8,24]. Post-embryonic depletion of prohibitins in C. 
elegans results in pronounced germline defects such as 
diminished oocyte production with smaller brood size 
[3], indicating that PHB proteins are specifically 
required in tissues that undergo cellular proliferation. 
Similarly, deletion of PHB2 in mouse embryonic 
fibroblasts results in severely impaired cellular 
proliferation [8]. Similarly, prohibitins are required for 
plant development [25,26] and are predominantly 
expressed in proliferating tissues [26]. PHB proteins are 
highly expressed in tissues that rely heavily on 
mitochondrial function and are particularly susceptible 
to mitochondrial dysfunction, including neurons, 
muscle, heart, liver, renal tubules, adrenal cortex, brown 
adipocytes and pancreatic islet cells [27]. Likewise, 
PHB proteins are expressed at high levels in 
mammalian proliferating cells, including neoplastic 
tissues [27,28], underscoring an essential role for 
prohibitins in regulating mitochondrial metabolism. 
 
Aging without prohibitin 
 
Disruption of the PHB complex in S. cerevisiae 
decreases the replicative lifespan of yeast cells 
[6,23,29], which is accompanied by morphological 
changes characteristic of aging cells [23]. PHB deple-
tion does not alter the chronological lifespan of non-
dividing (G0-arrested) cells. However, phb-null mutants 
in stationary phase tend to lose respiratory capacity due 
to deletions of the mitochondrial genome (mtDNA) 
[30]. Loss of mtDNA can only be detected in old, non-
dividing cells and not in young phb-null mother cells 
[6,31]. Similarly, defective mitochondrial segregation 
and aberrant mitochondrial morphology can only be 
detected in old phb-null mother cells at the end of their 
replicative lifespan [30]. This suggests that phb-null 
yeast cells undergo premature aging, probably due to a 
cumulative decline in cellular metabolic capacity. 
 
In C. elegans, depletion of prohibitins by RNAi reduces 
the lifespan of wild type animals [17], recapitulating the 
yeast aging phenotype. PHB depleted animals develop 
slightly slower than wild type, are smaller in size and 
have severely reduced brood sizes. In addition, the 
reduced pharyngeal pumping rates and longer defecation 
cycles of PHB-deficient animals are indicative of 
metabolically compromised animals [3]. Surprisingly, 
however, PHB depletion markedly extends the lifespan 
of a large variety of C. elegans mutants [17]. These 
include reduced insulin/insulin growth gactor 1 (IGF-1) 
and transforming growth factor beta (TGF-β) signaling 
mutants, mutants with altered fat metabolism, mito-
chondrial electron transport chain (ETC) mutants and 
dietary restricted animals. It is interesting to note that 
these effects are the result of RNAi-mediated knockdown 
of prohibitin genes mainly in non-neuronal C. elegans 
cells, given that neurons are particularly refractory to 
RNAi [32]. Since neuroendocrine signaling is a key 
modulator of aging in diverse species, it would be 
particularly relevant to understand the role of neuronal 
prohibitins in the aging process. We discuss the 
implications of these findings below. 
 
Diapause signaling and prohibitin function 
 
The Insulin/Insulin Growth Factor 1 (IGF-1) signaling 
pathway (IIS) regulates aging in worms, flies and 
mammals [33]. Mutations in the only C. elegans 
transmembrane insulin receptor kinase DAF-2 doubles 
the lifespan on wild type animals [34,35], and depletion 
of prohibitins further extends the lifespan of daf-2 
mutants by 150% [17]. The lifespan extension of daf-2 
mutants is dependent on the transcription factor DAF-
16/FOXO [33]. Similarly, loss of DAF-16 fully 
suppresses the exceptional longevity of PHB-depleted 
daf-2 mutants [17]. In addition to IGF signaling, the 
transforming growth factor beta (TGF-β) signal trans-
duction pathway also controls aging in C. elegans [36]. 
Prohibitin depletion extends the lifespan of animals 
defective in TGF-β signaling, including the TGF-β 
homologue daf-7 mutant and the transmembrane TGF-β 
receptor serine/threonine kinase daf-4 mutant. The highly 
conserved IGF-1 and TGF-β signaling pathways also 
regulate diapause entry (dauer larva formation) in the 
nematode [35,37]. The transmembrane guanylate cycl-
ase DAF-11, functions via both the insulin/IGF and the 
TGF-β pathways to modulate dauer formation [38]. 
Knock-down of phb-1 or phb-2 extends the lifespan of 
animals carrying a lesion in the daf-11 gene. Thus, 
depending on the genetic background, prohibitin function 
has opposing effects on C. elegans aging. Although 
depletion of prohibitin compromises survival of wild-
type animals, it substantially extends the lifespan of 
mutants defective in diapause signaling. Thus, the PHB 
complex plays an important role in modulating the rate of 
aging by coordinating mitochondrial energy metabolism 
in response to diapause signaling and energy demands. 
 
Mitochondria are involved in key aging associated proc- 
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esses, such as cellular metabolism, ATP synthesis and 
the production and detoxification of reactive oxygen 
species (ROS). Unpaired mitochondrial function has 
been shown to increase lifespan across phyla [39]. 
However, the molecular basis of the effect of 
mitochondrial dysfunction in aging is poorly under-
stood. PHB depletion by itself does not extend lifespan. 
However, it extends the lifespan of both, long-lived and 
short-lived, mitochondrial ETC defective animals. 
Knockdown of PHB genes extends the lifespan of gas-1 
mutants which carry a lesion in the 49-kDa iron-sulphur 
subunit of complex I of the ETC. Similarly, prohibitin 
depletion extends the lifespan of short-lived mev-1 
mutants, which are defective in succinate dehydrogen-
ase cytochrome b, a component of complex II. Muta-
tions in the isp-1 gene, encoding the Rieske iron-sulfur 
subunit of complex III, and in the clk-1 gene, involved 
in ubiquinone biosynthesis, extend the lifespan of C. 
elegans [29,40]. Prohibitin knockdown extends the 
lifespan of both, isp-1 and clk-1 mutant animals [17]. 
Therefore, reduced prohibitin activity promotes survival 
of animals with compromised mitochondrial function. 
Dietary restriction (DR) impacts on mitochondrial 
energy metabolism and on nutrient-sensing signaling 
pathways such as IIS and the target of rapamycin (TOR) 
signaling pathway [41]. Prohibitin deficiency improves 
the survival of dietary-restricted eat-2 mutants. Whether 
PHB effects on longevity are mediated by the effects of 
DR on mitochondrial metabolism, on cellular signaling 
or on both is currently unknown. 
 
Mitochondrial function is strongly linked to fat 
metabolism and altered fat metabolism accompanies the 
aging process. The C. elegans nuclear hormone receptor 
NHR-49 regulates fat mobilization by regulating the 
expression of a wide variety of genes, including 
mitochondrial fatty acid β-oxidation enzymes and fatty 
acid desaturases, such as FAT-7. Prohibitin deficiency 
extends the lifespan of both nhr-49 and fat-7 mutants 
[17]. Taken together, these findings indicate that 
prohibitin deficiency is beneficial for longevity in situa-
tions of altered growth factor signaling, defective 
mitochondrial function and altered fat metabolism. 
 
All the above data indicates that the metabolic state will 
determine whether prohibitin will promote or comp-
romise longevity. In agreement with this idea, a 
temperature shift is sufficient to revert the aging 
phenotype of PHB depletion. At higher temperature 
(25°C versus the standard 20°C growing conditions), 
where energy demands are higher and metabolic 
activity is elevated, prohibitin deficiency is beneficial 
for survival. Prohibitin deficiency is also beneficial 
under acute thermal stress (35°C), since elimination of 
PHB proteins render wild type animals strongly thermo-
tolerant. 
 
Prohibitins and the regulation of metabolism  
 
The link between mitochondrial energy metabolism and 
longevity has been most extensively studied in the 
nematode C. elegans. Many loss-of-function mutations 
in mitochondrial genes increase longevity [29,40,42-
45]; in addition, genome-wide RNAi screens have 
identified many mitochondrial genes which reduction 
results in increased lifespan. These include mostly 
components of the ETC and ATP synthase, TCA cycle 
enzymes and mitochondrial carrier proteins [46-50]. 
Prohibitins, however, do not belong to the lifespan-
extending class of mitochondrial genes, since disruption 
of PHB proteins shortens the lifespan of otherwise wild 
type animals. However, the remarkable increase in 
longevity that PHB depletion causes in metabolically 
compromised nematodes (e.g. IIS, mitochondrial ETC, 
fat metabolism and DR mutants) hints to an essential 
role of mitochondrial prohibitins in the regulation of 
cellular metabolism. 
 
Prohibitin depletion results in reduced fat content, in all 
genetic backgrounds where PHB deficiency extends 
lifespan [17]. In wild type animals, depletion of PHB 
proteins also reduces fat content early during adulthood; 
however, this effect is lost in aged adults, where fat 
levels become indistinguishable from that of wild type 
animals. A notable difference exists in the case of IIS 
and TGF-β mutants where fat levels remain 
extraordinary low during aging upon PHB depletion. It 
is plausible that, in order to sustain reproduction, 
metabolically compromised PHB deficient animals 
generate energy by burning fat. However, impairment 
of fat accumulation cannot be excluded. 
 
Mutations in the nhr-49 gene result in fat accumulation 
due to the reduced expression of mitochondrial fatty 
acid β-oxidation enzymes and nhr-49 mutants are short-
lived. PHB knockdown in nhr-49 mutants dramatically 
reduces fat content and extends longevity. NHR-49 
regulates the expression of the delta-9 stearoyl-CoA 
desaturase FAT-7, which is required for the synthesis of 
monounsaturated fatty acids [51]. PHB depletion 
reduces fat content and extends the longevity of fat-7 
mutants. These observations suggest that prohibitin 
deficiency engages fat metabolism to promote longevity 
in sensitized genetic backgrounds. 
 
How does PHB depletion affect mitochondrial activity 
to modulate aging? In wild type animals, prohibitin 
knockdown  results in  adult-onset  mitochondrial  over- 
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proliferation in the intestine. This is plausibly due to the 
activation of a cellular retrograde response to 
mitochondrial deficiency, which has been shown in 
yeast to induce mitochondrial biogenesis [52]. 
However, in all cases where prohibitin depletion 
extends longevity, mitochondrial intestinal content is 
reduced compared to controls. Thus, there seems to be 
an inverse correlation between mitochondrial content 
and longevity in PHB depleted animals. One possible 
explanation is that mitochondrial biogenesis is switched 
on to compensate for the lack or prohibitins in wild type 
animals, which in turn leads to increased defective 
mitochondria, increased ROS production and shorter 
lifespan. However, the exact signals that inhibit 
mitochondrial biogenesis in all cases where PHB 
deficiency increases longevity are currently unknown. 
 
Reduced fat and mitochondrial content upon PHB 
depletion correlate with extended longevity, however 
ATP content does not always correlate with extended 
longevity. Prohibitin knockdown significantly increases 
total ATP content in daf-2, daf-7, isp-1 and gas-1 
mutants. However, no ATP increase is observed in clk-
1, eat-2 and nhr-49 mutants. In particular, eat-2 and 
nhr-49 mutants depleted of prohibitins show less ATP 
content. Nevertheless, ATP content does not provide 
information about the capacity of ATP generation, since 
differences could be due to reduced or increased ATP 
consumption. ATP flux measurements should be much 
more informative. 
 
Oxidative stress and the requirement for prohibitins 
 
To date, there is no clear mechanistic explanation for 
the observed increased longevity of mitochondrial 
mutants. Mitochondria are major producers of ROS as a 
result of electron misplacement along the ETC. The free 
radical theory of aging postulates that ROS cause aging 
by inflicting cellular damage. In view of this theory, one 
possibility is that mitochondrial mutations might result 
in reduced rate of living and decreased ROS production 
[29]. In other cases, ETC dysfunction might result in 
increased electron leakage and ROS production, which 
will consequently activate an adaptive hormetic 
response being ultimately beneficial for longevity [53]. 
Treatment with the free-radical scavenger N-acetyl-
cysteine had no effect on longevity conferred by 
prohibitin knockdown in animals experiencing either 
oxidative stress (mev-1 mutants) or thermal stress (wild-
type nematodes grown at 25°C). Therefore, mito-
hormesis is unlikely to mediate the effects of prohibitin 
elimination on aging. 
 
Although a handful of data support the oxidative 
damage theory of aging, recent data from diverse 
organisms put the correlation between oxidative stress 
and aging into question [54]. Prohibitin depletion results 
in some paradoxical outcomes regarding oxidative 
stress resistance. In agreement with the mitochondrial 
free radical theory of aging, wild type animals depleted 
of prohibitins live shorter, show increased ROS 
production and are more sensitive to exogenously added 
oxidative stress in the form of paraquat. Depletion of 
prohibitins in wild type animals results in increased 
mitochondrial content, which might translate into an 
increased number of sites where ROS are produce. The 
situation is more complex in the case of daf-2(e1370) 
mutants. Although old daf-2(e1370) adults are more 
resistant to paraquat upon PHB depletion, paraquat 
treatment results in the same level of ROS production in 
daf-2(e1370) adult animals regardless of the presence or 
the absence of the PHB complex. Moreover, surprise-
ingly, L4 daf-2(e1370) larvae are clearly more sensitive 
to paraquat in the absence of the PHB complex, despite 
the final output being extraordinarily increased lifespan. 
 
Certainly, mitochondrial dysfunction upon prohibitin 
depletion results in more intricate physiological 
responses than increasing or reducing ROS levels and 
oxidative damage and unveiling the mechanisms 
implicated in mitochondrial-mediated life extension is 
crucial to understand how lifespan is regulated. 
 
Prohibitins and cellular signaling 
 
A feasible mechanism involved in the lifespan 
extension conferred by prohibitin depletion is cellular 
signaling and the activation of alternative metabolic 
routes that will counter the mitochondrial defect. Long 
lived yeast mitochondrial mutants activate a retrograde 
signaling pathway that results in the activation of 
specific transcription factors that will shift metabolism 
away from the Krebs cycle towards the glyoxylate 
cycle. This metabolic shift has also been observed in 
dauer larvae and long-lived daf-2 mutants [55,56]. It is 
possible that a metabolic shift also contributes to the 
extended lifespan of certain PHB-depleted C. elegans 
mutants. Although depletion of PHB does not affect the 
lifespan of the glyoxylate mutant gei-7 (our unpublished 
observation) it would be interesting to see if gei-7 is 
required in the mutant genetic backgrounds where PHB 
elimination extends lifespan. 
 
It is generally believed that mitochondrial dysfunctions 
exert their effect on lifespan independently of the IIS 
pathway, because they show a synergistic effect with 
daf-2 mutations and extend lifespan independently of 
DAF-16 [29,40,47,50]. However, some mitochondrial 
mutations require DAF-16 for lifespan extension and 
influence its nuclear localization [46,50]. Mitochondrial 
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defects are associated with insulin resistance and 
diabetes and IIS regulates metabolism and the response 
to oxidative stress. Therefore, alteration of mitochondr-
ial function is likely to affect longevity, through 
components of the IIS pathway. We have recently 
uncovered a surprising interaction of mitochondrial 
prohibitins with IIS in the regulation of longevity, 
which is dependent on the transcription factor DAF-16/ 
FOXO. However, the increased thermotolerance confer-
red by PHB-depletion is, at least partially, DAF-16/ 
FOXO independent, indicating that other pathways are 
involved in the metabolic changes elicited by prohibitin 
deficiency. 
 
Reduced AMP/ATP ratios activate the AMP-activated 
protein kinase (AMPK). The C. elegans aak-2/AMPK 
is partially required for the life extension of daf-2 and 
mitochondrial mutants [57,58]. The aak-2/AMPK 
kinase is required for the reduced fat content 
phenotype elicited by PHB depletion, and knockdown 
of prohibitins shortens the lifespan of aak-2 mutants. 
On the other hand, aak-2 mutants show increased 
mitochondrial biogenesis, which is further enhanced 
by PHB elimination [17]. AMPK targets p53 to 
promote cell survival under conditions of nutrient 
deprivation [59] and it has been suggested that        
cell cycle checkpoint control plays an important role     
in specifying longevity of mitochondrial mutants   
[60]. Prohibitin deficiency shortens the lifespan         
of p53 (cep-1) mutant animals, however, it would be 
necessary to examine the requirement of p53 in the 
























The mitogen activated protein kinase (MAPK) JNK-1, 
is also required for the reduction of fat content in animals 
lacking prohibitins. On the one hand mitochondrial 
content is higher in jnk-1 mutants and remains unchanged 
after prohibitin removal. On the other hand, overexpress-
ion of JNK-1 in wild-type animals reduces mitochondrial 
content and suppresses mitochondrial proliferation upon 
prohibitin depletion. phb gene knock-down shortens the 
lifespan of animals lacking JNK-1 and extends the 
lifespan of animals overexpressing JNK-1. Overexpress-
ion of JNK-1 promotes DAF-16/FOXO nuclear local-
ization under conditions of stress [61]. Similarly, mut-
ations in the Akt/PKB homologue AKT-1, which trans-
duces insulin/IGF-1 signals [62], result in reduced mito-
chondrial content, which does not increase upon pro-
hibitin depletion. AKT-1 mutations also promote DAF-
16/FOXO nuclear localization, raising the possibility of 
DAF-16/FOXO being involved in the inhibition of 
mitochondrial biogenesis. Conversely, AKT-1 is not 
required for the reduction of fat content in phb deficient 
animals [17]. 
 
There is an urgent need to gain more insight into the 
transcriptional regulation and the signaling cascades 
involved in the regulation of lipid metabolism and 
mitochondrial biogenesis in response to PHB deple- 
tion in wild type animals and in the mutants where 
PHB depletion extends lifespan. This will allow delin-  
eating the molecular genetic pathways of PHB 
function as well as the molecular pathways invol-    
ved in the crosstalk between mitochondria and cell-       






























results  in  mitochondrial  defects  and  elicits  a  retrograde  cellular  response  leading  to  mitochondria  overproliferation  and  altered  fat 
metabolism.  In  turn, accumulation of defective mitochondria  lacking prohibitin  results  in  increased reactive oxygen species production, 
metabolic defects, consequent cellular damage and reduced lifespan. Under reduced diapause signaling or under stress, where AKT/SGK‐





Mitochondrial mutations result in pleiotrophic effects 
and possibly, different mutations will affect the aging 
rate differently and in a tissue specific manner. Aging is 
a hormonally regulated process; therefore, it is essential 
to understand when and in which specific tissues PHB 
depletion exerts its beneficial effects on longevity. The 
striking longevity phenotype observed upon prohibitin 
elimination in diapause mutants is, to our knowledge, 
the first example of a genetic manipulation with 
context-dependent, opposing effects on aging (Figure 
1). Thus, prohibitins represent the first and only case, 
until now, of a protein that affects longevity in sharply 
opposing ways depending on the metabolic state. This 
indicates that important genes in the regulation of aging 
might have been overlooked because they only manifest 
their effects under certain conditions relevant to the 
aging process. Given the high degree of evolutionary 
conservation of prohibitins and the biochemical 
pathways involved in lifespan regulation, we anticipate 
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